COA/KL-2026-023Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
KLOW 80 mg
KL-2026-023Lot klowclearcapsAnalyzed November 17, 2026

Timeline
Ordered
November 8, 2026
Received
November 16, 2026
Analyzed
November 17, 2026
Sample
Name
KLOW 80 mg
Expected
KLOW blend (GHK-Cu, BPC-157, TB-500, KPV)
Amount
1 vial, lyophilized powder
Testing
Client
Los Angeles Compounds
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
GHK-Cu45.6mg
Label claim: 50 mg
BPC-15715.20mg
Label claim: 10 mg
TB-500, fragment form (Ac-LKKTETQ)12.37mg
Label claim: 10 mg
Thymosin beta-4, full lengthNotdetected
KPV11.81mg
Label claim: 10 mg
Purity, how clean it is
99.7%
Peptide purity, HPLC-UV peak area
Chromatograms
BPC-157 / TB-500
HPLC-UV
11.40 min, BPC-157
6.73 min, TB-500 (fragment)
GHK-Cu / KPV
HPLC-UV
2.58 min, GHK-Cu
3.61 min, KPV
Analyst Comments
Blue lyophilized powder, clear-cap vial, received sealed. GHK-Cu and KPV were measured on a second HPLC-UV method; both chromatograms are shown.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 17, 2026
Verification Code
KL-5W8V-5QUN
Verify at purilab.org/verify/KL-5W8V-5QUN
Scan to Verify
KL-5W8V-5QUN
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1